Literature DB >> 23951504

Osteoporosis drugs most effective in women at high fracture risk.

.   

Abstract

Entities:  

Year:  2012        PMID： 23951504      PMCID： PMC3727846          DOI： 10.1038/bonekey.2012.124

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.

Authors:  Eugene V McCloskey; Helena Johansson; Anders Oden; Matt Austin; Ethel Siris; Andrea Wang; E Michael Lewiecki; Roman Lorenc; Cesar Libanati; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.